The Impact of Clinical Pharmacist Support on Patients Receiving Multi-drug Therapy for Coronary Heart Disease in China

about

Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China.

P2860

Q38949163-E29EA975-D44C-448D-A928-3DCFD7896E53

P2860

The Impact of Clinical Pharmacist Support on Patients Receiving Multi-drug Therapy for Coronary Heart Disease in China

Item

http://www.wikidata.org/entity/Q35851247

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

The Impact of Clinical Pharmac ...... oronary Heart Disease in China

@ast

The Impact of Clinical Pharmac ...... oronary Heart Disease in China

@en

type

Item

label

The Impact of Clinical Pharmac ...... oronary Heart Disease in China

@ast

The Impact of Clinical Pharmac ...... oronary Heart Disease in China

@en

prefLabel

The Impact of Clinical Pharmac ...... oronary Heart Disease in China

@ast

The Impact of Clinical Pharmac ...... oronary Heart Disease in China

@en

P1476

The Impact of Clinical Pharmac ...... oronary Heart Disease in China

@en

P2093

H W Zhao

http://www.w3.org/2001/XMLSchema#string

S Du

http://www.w3.org/2001/XMLSchema#string

S J Zhao

http://www.w3.org/2001/XMLSchema#string

Y H Qin

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Psychodynamic Motivation and Training program (PMT) for the secondary prevention in patients with stable coronary heart disease: study protocol for a randomized controlled trial of feasibility and effects

Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials.

Clopidogrel with or without omeprazole in coronary artery disease.

Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease.

Cardiac rehabilitation patient and organizational factors: what keeps patients in programs?

A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease.

Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital.

Psychosocial functioning and quality of life in adults with congenital heart disease and heart failure.

P304

306-311

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0250-474X.159632

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26180276

http://www.w3.org/2001/XMLSchema#string

P932

4502145

http://www.w3.org/2001/XMLSchema#string

The Impact of Clinical Pharmacist Support on Patients Receiving Multi-drug Therapy for Coronary Heart Disease in China

about

P2860

P2860

The Impact of Clinical Pharmacist Support on Patients Receiving Multi-drug Therapy for Coronary Heart Disease in China

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932